Search hospitals > Illinois > Rockford
OSF Saint Anthony Medical Center
Claim this profileRockford, Illinois 61108
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
65 reported clinical trials
2 medical researchers
Summary
OSF Saint Anthony Medical Center is a medical facility located in Rockford, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. OSF Saint Anthony Medical Center is involved with conducting 65 clinical trials across 112 conditions. There are 2 research doctors associated with this hospital, such as Shylendra B. Sreenivasappa and Iftekhar U. Ahmad.Area of expertise
1Cancer
Global LeaderStage II
HER2 positive
Stage I
2Breast Cancer
Global LeaderER positive
Stage II
HER2 positive
Top PIs
Shylendra B. SreenivasappaOSF Saint Anthony Medical Center4 years of reported clinical research
Studies Cancer
Studies Lung Cancer
14 reported clinical trials
26 drugs studied
Iftekhar U. AhmadOSF Saint Anthony Medical Center4 years of reported clinical research
Studies Cancer
Studies Lung Cancer
8 reported clinical trials
15 drugs studied
Clinical Trials running at OSF Saint Anthony Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Squamous Cell Carcinoma
ALK Gene Rearrangement
Colorectal Cancer
Adenoma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at OSF Saint Anthony Medical Center?
OSF Saint Anthony Medical Center is a medical facility located in Rockford, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. OSF Saint Anthony Medical Center is involved with conducting 65 clinical trials across 112 conditions. There are 2 research doctors associated with this hospital, such as Shylendra B. Sreenivasappa and Iftekhar U. Ahmad.